# Bronchoscopy Market

> Bronchoscopy Market Size, Growth Research Report By Product (Endoscope, Visualization & Documentation Systems, Accessories, and Other), by Usability (Disposable Equipment and Reusable Equipment) by Application (Bronchial Diagnosis and Bronchial Treatment) by End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Competitor Industry Analysis and Trends Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.6%
- **2024:** $ 2.89 Billion
- **2025:** $ 3.11 Billion
- **2035:** $ 6.48 Billion
- **Key Players:** Companies such as Medtronic (US), Boston Scientific (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP), Conmed Corporation (US), Hoya Corporation (JP), Ambu A/S (DK) are some of the major participants in the global market.

**Report ID:** MRFR/HC/9988-HCR · **Pages:** 150 · **Author:** Rahul Gotadki · **Last Updated:** May 13, 2026

**URL:** https://www.marketresearchfuture.com/reports/bronchoscopy-market-11508

---

## Market Summary

## **Global Bronchoscopy Market Overview**

The bronchoscopy market size was valued at USD 2.3 billion in 2021 and is projected to grow from USD 2.5 Billion in 2022 to USD 4.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6% during the forecast period (2022 - 2030). The rising prevalence of lung cancer, increasing research and development activity, and increasing business expansion activity by major key players deployment are driving the market growth. 

May 2024 saw the introduction of two new bronchoscopes by the Olympus Corporation. They are compatible with the EVIS X1 Endoscopy System, which is now the latest in diagnosis and treatment technology, and boast advanced imaging. Unlike previous models, the two new bronchoscopes possess slim outer diameters which enable better usability by physicians. 

## **Bronchoscopy Market Trends**

The increasing prevalence of respiratory disease is propelling the market growth of bronchoscopy. The increasing prevalence of respiratory disease such as lung cancer, asthma, chronic obstructive pulmonary disease (COPD). In addition, rising demand for advanced therapeutics further boosts the growth of this market. For Instance, in 2020, as per the World Cancer Research Fund International lung cancer is the second most common cancer across the globe. It is the most common cancer in men and second most common cancer in women. There were more than 2.2 million new cases of lung cancer reported in 2020.

The ten countries including Hungary, Serbia, France, Turkey, Montenegro, Belgium, Bosnia and Herzegovina, and Denmark are the highest number of deaths from lung cancer in 2020. Moreover in 2020, around 545 million patients will live with a chronic respiratory condition which represents 7.4% of world population which increasing burden on healthcare sector as well as directly influence the market demand of bronchoscopy.

**Figure 1: Global Bronchoscopy by Product 2021 & 2030 (USD BILLION)**

## **Bronchoscopy Market Segment Insights:**

### **Bronchoscopy Product Insights**

The market segments of bronchoscopy, based on product is further segmented into endoscope, visualization & documentation systems, accessories, and other. The endoscope segment is to hold the majority share in 2021 in the Bronchoscopy Market revenue. This is due to the rising prevalence of lung cancer, increase the use of endoscopy equipment and technological development. For instance: In 2023, around 238,340 adults (117,550 men and 120,790 women) in the US were diagnosed with lung cancer. Worldwide, approximately 2,206,771 people were diagnosed with lung cancer in 2020. These statistics involve both small cell lung cancer and non-small cell lung cancer.

In addition, visualization & documentation systems are expected to grow at a healthy CAGR of 6.5% over the forecast period.

In August 2023, Ambu reported that it had received a 510k notification from the FDA for its Ambu aScope 5 Broncho, fifth-generation bronchoscope series. The two new models are single-use endoscopes intended for high-complexity procedures.

### **Bronchoscopy Usability Insights**

The Bronchoscopy Market segmentation is based on usability that includes disposable equipment and reusable equipment. The reusable equipment segment has dominated the market in multi-usage and cost-effectiveness are the key advantages these devices offer. As a result, more than 500 bronchoscopy procedures are performed in a year.

**Figure 2: BRONCHOSCOPY MARKET, BY USABILITY, 2021 & 2030 (USD BILLION)**

****

### **Bronchoscopy Application Insights**

The Market segmentation of Bronchoscopy is based on application that bronchial diagnosis and bronchial treatment. The bronchial treatment has dominated the market in 2021 and is projected to be the fastest-growing segment during the forecast period, 2022-2030. This is due to the increasing awareness about lung cancer, availability of advance treatment solutions is further driving the growth of bronchial treatment in the market.

### **Bronchoscopy End User Insights**

The market segmentation of bronchoscopy is based on end-user that includes hospitals & clinics, ambulatory surgery centers. The hospitals & clinics segment has dominated the market in 2021 and is projected to be the fastest-growing segment during the forecast period, 2022-2030. This is due to the availability of easy availability of patient advance treatment, increasing patient pool in hospitals. Moreover, the increasing government support for development of better medical facility also drives the growth of hospitals and clinics segment.

### **Bronchoscopy Regional Insights**

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America bronchoscopy market accounted for USD 1.5 billion in 2021 and is expected to exhibit a 5.2% CAGR during the study period. This is attributed to the presence of key players, high prevalence rate of lung cancer, increasing cases of COPD disease in US, availability of advance treatment is further boosting the market growth of bronchoscopy in North America.

For instance: In 2021 more than 25 million patients in US suffered from asthma as well as more than 16 million people in the US had COPD (chronic obstructive pulmonary disease), which is cause of death. Moreover, the American Cancer Society in 2023 approximate 238,340 new cases of lung cancer as well as 127,070 deaths from lung cancer reported in US. Thus, increasing prevalence of lung cancer, rising new cases of asthma, and the presence of major key players is further boosting the market growth in North America.

As per the Canadian Cancer Society approximate 30,000 Canadians was diagnosed with lung cancer and bronchus cancer. This indicates 13% of all new cancer cases in 2022.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 3: BRONCHOSCOPY MARKET SHARE BY REGION, 2021 & 2030 (USD BILLION)**

****

Europe bronchoscopy market is expected to account for the second-largest market share due to increasing investment in healthcare expenditure, technological advancements, increasing advancement in bronchoscopy, a rising regulatory approval for bronchoscope portfolio. For instance: In May 2021, Pantax Medical Europe received CE mark for its single use bronchoscope PulmoONE. This advanced technological product offers high quality care with advanced care in pulmonary care. The PulmoONE is a single use bronchoscope with advance power and HD image quality. Thus, rising product approval, technological developments, rising healthcare expenditure are further boosting the market growth of bronchoscopy in Europe region.

The Asia-Pacific bronchoscopy market is expected to fastest be growing from 2022 to 2030. This Asia-Pacific is expected to grow at the fastest CAGR of 7.0% during the forecast period. Rising research and development activity, easy availability of labour cost, growing use of advance bronchoscopy technology use in hospitals, increasing statergic alliance such as merger, acquisition, agreement, and collaboration are rising market scope of bronchoscopy in Asia-Pacific region. For instance: In March 2023, Yashoda Hospitals in India, and Asia to utilize advance diagnostic bronchoscopy technology with LungVision AI driven intraoperative CT imaging.

Thus, rising strategic decision by key players, highly investment major key players for research and development activity are drive the market growth of bronchoscopy in Asia-Pacific region.

The rest of the world is comprised of the Middle East, Africa, and Latin America. This segment is projected to hold the least market share. In this region, the Middle East is anticipated to dominate due to the improving medical facility, growing investment in healthcare infrastructure, rising consumption of tobacco leads to the risk of lung cancer which is directly influence the market demand of bronchoscopy in the Rest of the World.

**Bronchoscopy Key Market Players & Competitive Insights**

The Bronchoscopy Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by medical devices and research scientists operating in the industry. The major players heavily invest in research and development activity across the globe with varied product portfolios.

Companies such as Olympus Corporation (Japan), Teleflex, Inc. (US), Ambu A/S (Denmark), Karl Storz GmbH (Germany), Fujifilm Holdings Corporation (Japan) dominate the Market of Bronchoscopy due to strong brand image, extensive business network across the globe, heavily investment in research and development activity, financial stability, statergic alliance, and wide business presence in across the globe. The key players are focused on the development of new products. Moreover, they adopt growth initiatives, such as collaboration, product launches, mergers, and acquisition, to strengthen their market position and gain a large customer base.

One of the primary business strategies adopted by manufacturers in the global bronchoscopy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. Olympus Corporation (Japan) is a global medical device company which is engage in development of optics and reprography products. The company distributes its products in more than 40 countries. The company holds around 17,000 patents as well as acquiring new technology to build up its business across the globe.

For instance: In May 2022, Olympus Corporation, a Japanese manufacturer of optics and reprography products signed a group purchasing agreement with Premier, Inc. in the Single-Use Visualization Devices category for their single-use bronchoscope portfolio.

Teleflex Incorporated (US) is a medical technology company which design and develop various healthcare products. The company product portfolio is diverse around emergency medicine, surgical, vascular access, interventional cardiology and radiology, anaesthesia, and respiratory care. It offers product under the segment of surgical, respiratory, interventional urology, and urology. The company operated its business in more than 150 countries.

**Key Companies in the Market of Bronchoscopy Include.**

### Bronchoscopy Market Industry Developments

- **Q2 2024: Olympus launches EVIS X1, its most advanced endoscopy system, in the United States** Olympus announced the U.S. launch of its EVIS X1 endoscopy system, which includes advanced bronchoscopy capabilities designed to improve diagnostic and therapeutic procedures for respiratory diseases.
- **Q1 2024: Ambu receives FDA 510(k) clearance for Ambu® aScope™ 5 Broncho** Ambu announced it received FDA 510(k) clearance for its aScope 5 Broncho, a single-use bronchoscope designed for advanced bronchoscopy procedures in the U.S. market.
- **Q2 2024: Boston Scientific launches EXALT Model B single-use bronchoscope in Europe** Boston Scientific announced the commercial launch of its EXALT Model B single-use bronchoscope in select European markets, expanding its portfolio of disposable endoscopy solutions.
- **Q1 2024: Fujifilm launches new ELUXEO Ultra bronchoscopy system in Japan** Fujifilm introduced the ELUXEO Ultra bronchoscopy system in Japan, featuring enhanced imaging technology for improved detection and diagnosis of pulmonary diseases.
- **Q2 2024: Medtronic acquires privately held bronchoscopy device maker InterVapor for $350 million** Medtronic announced the acquisition of InterVapor, a company specializing in minimally invasive bronchoscopy devices for lung disease treatment, to strengthen its respiratory portfolio.
- **Q1 2024: Olympus and Veran Medical Technologies announce strategic partnership for advanced bronchoscopy navigation** Olympus and Veran Medical Technologies entered a partnership to integrate Veran’s navigation technology with Olympus’ bronchoscopy systems, aiming to improve accuracy in lung cancer diagnosis.
- **Q2 2024: Ambu opens new manufacturing facility for single-use endoscopes in Mexico** Ambu inaugurated a new manufacturing facility in Mexico to increase production capacity for its single-use bronchoscopes and meet growing global demand.
- **Q1 2024: Boston Scientific receives CE Mark for EXALT Model B single-use bronchoscope** Boston Scientific announced it received CE Mark approval for its EXALT Model B single-use bronchoscope, allowing commercialization in the European Union.
- **Q2 2024: Fujifilm opens new R&D center for endoscopy innovation in Germany** Fujifilm opened a new research and development center in Germany focused on advancing endoscopy and bronchoscopy technologies for the European market.
- **Q1 2024: Karl Storz appoints new CEO to drive digital transformation in endoscopy** Karl Storz announced the appointment of a new CEO, emphasizing a strategic focus on digital innovation and expansion in the bronchoscopy and endoscopy sectors.
- **Q2 2024: Olympus receives FDA clearance for BF-UC190F endobronchial ultrasound bronchoscope** Olympus announced it received FDA clearance for its BF-UC190F endobronchial ultrasound bronchoscope, expanding its portfolio of advanced diagnostic tools for lung cancer.
- **Q1 2024: Ambu secures contract to supply single-use bronchoscopes to major U.S. hospital network** Ambu announced it secured a multi-year contract to supply its single-use bronchoscopes to a leading U.S. hospital network, supporting infection control and procedural efficiency.

## **Bronchoscopy Market Segmentation**

### **Bronchoscopy Product Outlook**

### **Bronchoscopy Usability Outlook**

### **Bronchoscopy Application Outlook**

### **Bronchoscopy End User Outlook**

### **Bronchoscopy Regional Outlook**

## Market Drivers

### Growing Awareness and Education

The rising awareness regarding the importance of early diagnosis and treatment of respiratory diseases is significantly influencing the Bronchoscopy Market. Educational initiatives aimed at both healthcare professionals and patients are fostering a better understanding of bronchoscopy procedures and their benefits.
 
This increased awareness is likely to lead to higher patient referrals for bronchoscopy, as individuals become more proactive about their respiratory health. Furthermore, healthcare providers are investing in training programs to enhance the skills of practitioners in performing bronchoscopy, which may contribute to improved procedural outcomes. As a result, the market is expected to expand as more patients seek these essential diagnostic services.

### Increase in Geriatric Population

The demographic shift towards an aging population is a significant factor driving the Bronchoscopy Market. Older adults are more susceptible to respiratory diseases due to age-related physiological changes and comorbidities. As the global population ages, the demand for bronchoscopy procedures is likely to increase, as these individuals often require advanced diagnostic and therapeutic interventions for respiratory conditions.
 
Data suggests that the geriatric population is projected to grow substantially in the coming years, further emphasizing the need for effective healthcare solutions. Consequently, the market is expected to benefit from this demographic trend, as healthcare systems adapt to meet the needs of an older population.

### Rising Incidence of Respiratory Diseases

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a primary driver of the Bronchoscopy Market. According to recent data, respiratory diseases account for a significant portion of global morbidity and mortality. The World Health Organization indicates that COPD alone affects millions worldwide, necessitating advanced diagnostic and therapeutic interventions.
 
As healthcare systems strive to address this growing burden, the demand for bronchoscopy procedures is likely to rise. This trend is further supported by the development of innovative bronchoscopy technologies that enhance diagnostic accuracy and treatment efficacy. Consequently, the market is poised for substantial growth as healthcare providers seek effective solutions to manage and treat respiratory conditions.

### Technological Innovations in Bronchoscopy

Technological advancements play a crucial role in shaping the Bronchoscopy Market. Innovations such as robotic-assisted bronchoscopy and advanced imaging techniques have revolutionized the field, allowing for more precise and less invasive procedures.
 
For instance, the introduction of electromagnetic navigation bronchoscopy has improved the ability to access peripheral lung lesions, which was previously challenging. These advancements not only enhance patient outcomes but also increase the efficiency of procedures, thereby attracting more healthcare facilities to adopt bronchoscopy technologies. As a result, the market is experiencing a surge in demand for these cutting-edge tools, which are expected to drive growth in the market over the coming years.

### Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are essential drivers of the Bronchoscopy Market. Governments and health organizations are increasingly recognizing the value of bronchoscopy in diagnosing and treating respiratory diseases, leading to improved reimbursement rates for these procedures.
 
This financial support encourages healthcare providers to invest in bronchoscopy technologies and expand their service offerings. Additionally, regulatory bodies are streamlining approval processes for new bronchoscopy devices, facilitating quicker access to innovative solutions. As a result, the market is likely to experience growth as healthcare providers are incentivized to adopt and implement advanced bronchoscopy techniques.

## Future Outlook

The Bronchoscopy Market size is projected to reach USD 6.479 Billion by 2035, growing at a CAGR of 7.6%, driven by technological advancements, increasing respiratory diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of AI-driven diagnostic tools for enhanced accuracy Expansion of telemedicine platforms for remote bronchoscopic consultations Investment in minimally invasive bronchoscopic techniques for outpatient procedures

By 2035, the Bronchoscopy Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Endoscope (Largest) vs. Accessories (Fastest-Growing)

In the Bronchoscopy Market, the endoscope segment accounts for the largest 62% share, driven by its critical role in enabling both diagnostic and therapeutic procedures. Coupled with the increasing prevalence of respiratory disorders, this segment benefits from advancements in technology, enhancing the efficacy and safety of bronchoscopic procedures. Accessories follow closely, comprising a significant portion of the market due to their essential role in facilitating various applications across bronchoscopy applications. The diverse range of accessories also caters to the growing customization needs in clinical settings, ensuring optimal performance for clinicians and improved outcomes for patients, supporting broader market segmentation bronchoscopy analysis.

Endoscope (Dominant) vs. Accessories (Emerging)

The Endoscope segment, regarded as the dominant force in the Bronchoscopy Market, is crucial for providing direct visualization of the respiratory tract. Modern endoscopes incorporate state-of-the-art imaging technologies, boosting their utility in diagnostics and interventions. Meanwhile, the Accessories segment is characterized by rapid growth as it increasingly adopts advanced materials and designs to support procedural efficiency and patient safety. This surge can be attributed to innovations aimed at enhancing equipment compatibility and user experience. Furthermore, the rising demand for personalized treatment options is driving accessory manufacturers to expand their product lines, positioning them as an emerging force to complement the continued dominance of endoscopes in the bronchoscopy landscape, including innovations relevant to the ent bronchoscopy devices market.

### By Usability: Disposable Equipment (Largest) vs. Reusable Equipment (Fastest-Growing)

In the bronchoscopy market, the usability segment reflects a clear split between disposable and reusable equipment, with disposable devices accounting for a dominant 58% share, driven by their convenience and growing preference for single-use products in clinical settings. On the other hand, reusable equipment captures a smaller percentage but is gaining traction as healthcare facilities focus on sustainability and cost-effectiveness, leading to innovative developments in this category.

Usability: Disposable Equipment (Dominant) vs. Reusable Equipment (Emerging)

Disposable equipment has emerged as the dominant force in the bronchoscopy market, favored for its hygiene, ease of use, and compliance with infection control guidelines. As healthcare practices evolve, the demand for single-use bronchoscopes and related tools is on the rise, driven by heightened awareness of cross-contamination risks. Conversely, reusable equipment is positioned as the emerging option, appealing to healthcare facilities aiming to reduce waste and manage costs effectively. Innovation in reprocessing technologies and design improvements are enabling reusable devices to enhance their appeal, making them a viable alternative as healthcare providers balance operational efficiency with patient safety.

### By Application: Bronchial Diagnosis (Largest) vs. Bronchial Treatment (Fastest-Growing)

In the Bronchoscopy Market, the application segment shows a significant distribution, with bronchial diagnosis accounting for the leading 64% share, driven by its essential role in detecting and evaluating respiratory conditions. This dominant position is attributed to its essential role in early detection of respiratory diseases, which is becoming increasingly important in healthcare. Meanwhile, Bronchial Treatment, while currently smaller in share, is rapidly gaining traction due to advancements in minimally invasive techniques and personalized medicine approaches, catering to diverse patient needs across emerging areas such as the fibrotic market.

Bronchial Diagnosis (Dominant) vs. Bronchial Treatment (Emerging)

Bronchial Diagnosis stands out as the dominant application in the Bronchoscopy Market, emphasizing its critical importance in diagnosing various respiratory conditions. It employs advanced imaging and diagnostic technologies, enabling healthcare professionals to identify issues such as tumors, infections, and chronic illnesses effectively. On the other hand, Bronchial Treatment is emerging as a vital segment, propelled by innovations in therapeutic techniques and drug delivery systems. As healthcare shifts towards targeted therapies, the Bronchial Treatment segment is set to expand its footprint, making it an essential area for future market growth.

### By End User: Hospitals & Clinics (Largest) vs. Ambulatory Surgery Centers (Fastest-Growing)

In the bronchoscopy market, the end-user segment is dominated by hospitals and clinics, which account for the largest 68% market share, supported by their advanced infrastructure and comprehensive diagnostic capabilities. This segment benefits from the high volume of procedures performed in these settings as they are equipped with advanced technology and specialized healthcare professionals. Additionally, the accessibility of these facilities to a wide patient demographic contributes significantly to their commanding position in the market. On the other hand, ambulatory surgery centers are emerging as a notable player in the market. Their market share is rapidly increasing due to the rise in preference for outpatient procedures, enabling patients to receive care in a more cost-effective and convenient environment. The growth trends in the market for end-users show a clear shift towards ambulatory surgery centers, which are recognized for their efficiency and effectiveness in terms of patient throughput and recovery times. This is further driven by the increasing demand for minimally invasive procedures, which are mainly conducted in these centers. Hospitals and clinics must innovate and improve their services to compete effectively with the growing preference for ambulatory care. Furthermore, the rising patient awareness about surgical options and advancements in bronchoscopy technology are propelling both segments, but particularly favoring the agility and accessibility offered by ambulatory surgery centers.

Hospitals & Clinics (Dominant) vs. Ambulatory Surgery Centers (Emerging)

Hospitals and clinics represent the dominant segment in the bronchoscopy market, characterized by comprehensive care options and extensive surgical facilities. This segment benefits from wider patient access due to established trust and long-standing relationships with communities. Their ability to provide a full range of medical services enhances patient retention and encourages referrals. Conversely, ambulatory surgery centers are emerging as a pivotal segment, primarily because of their focus on patient-centered care and reduced wait times. These centers are designed for outpatient procedures, allowing for quicker recovery and diminished hospital stays, making them increasingly appealing. Technological advancements and a growing emphasis on non-invasive procedures within these centers support their rapid market growth, establishing them as formidable competitors to traditional hospitals and clinics.

## Regional Market Share Analysis

### North America : Healthcare Innovation Leader

North America is the largest market for bronchoscopy, holding approximately 45% of the global share, driven by advanced healthcare infrastructure, increasing prevalence of respiratory diseases, and technological innovations, contributing significantly to the bronchoscopy market size. Regulatory support from agencies like the FDA has further catalyzed market growth, ensuring the availability of cutting-edge bronchoscopy devices and procedures.

The demand for minimally invasive procedures is also on the rise, contributing to market expansion. The United States leads the North American market, with significant contributions from Canada. Key players such as Medtronic, Boston Scientific, and Olympus Corporation dominate the competitive landscape, focusing on product innovation and strategic partnerships. The presence of well-established healthcare facilities and a growing emphasis on early diagnosis and treatment of respiratory conditions are pivotal in shaping the market dynamics in this region.

### Europe : Emerging Market Dynamics

Europe Bronchoscopy Market accounted for 30% share in 2024, generating around USD 0.87 billion, making it the second-largest regional market, with strong development across the medical market. The region is witnessing growth driven by increasing awareness of respiratory diseases, advancements in medical technology, and supportive regulatory frameworks. The European Medicines Agency (EMA) has been instrumental in streamlining the approval processes for new bronchoscopy devices, enhancing market accessibility and innovation. Germany, France, and the UK are the leading countries in this market, with a strong presence of key players like Karl Storz and Fujifilm Holdings Corporation. The competitive landscape is characterized by a mix of established companies and emerging startups focusing on innovative bronchoscopy solutions. The growing demand for outpatient procedures and the integration of digital technologies in healthcare are also shaping the market's future.

### Asia-Pacific : Rapidly Growing Market

Asia-Pacific is an emerging powerhouse in the bronchoscopy market, holding approximately 20% of the global share. The region is experiencing rapid growth due to rising healthcare expenditures, increasing prevalence of chronic respiratory diseases, and a growing geriatric population. Governments are investing in healthcare infrastructure, which is expected to further boost the demand for bronchoscopy procedures and devices in the coming years. China, Japan, and India are the leading countries in this market, with significant contributions from local and international players. Companies like Hoya Corporation and Ambu A/S are expanding their presence in the region, focusing on affordable and innovative bronchoscopy solutions. The competitive landscape is evolving, with an increasing number of partnerships and collaborations aimed at enhancing product offerings and market reach.

### Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the bronchoscopy market, currently holding about 5% of the global share. The growth is driven by increasing awareness of respiratory diseases, rising healthcare investments, and the need for advanced medical technologies. Governments are focusing on improving healthcare infrastructure, which is expected to enhance the accessibility of bronchoscopy procedures in the region. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities adopting advanced bronchoscopy technologies. The competitive landscape is characterized by a mix of local and international players, with companies looking to establish a foothold in this untapped market. The increasing prevalence of respiratory conditions is likely to drive demand for bronchoscopy solutions in the coming years.

## Competitive Benchmarking

The Bronchoscopy Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of respiratory diseases, reinforcing insights derived from bronchoscopy market research. Key players such as Medtronic (US), Boston Scientific (US), and Olympus Corporation (JP) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its technological capabilities.
 
Olympus Corporation (JP) is known for its commitment to research and development, which allows it to maintain a competitive edge in the market. Collectively, these strategies contribute to a robust competitive environment, fostering growth and innovation within the industry. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach appears to be particularly relevant in the context of the Bronchoscopy Market, which is moderately fragmented, with several players vying for market share.
 
The collective influence of key players shapes the market structure, as they engage in strategic collaborations and optimize their operations to meet the evolving demands of healthcare providers. In August 2025, Medtronic (US) announced the launch of its latest bronchoscopy system, which integrates advanced imaging technology to improve diagnostic accuracy. This strategic move is significant as it not only enhances Medtronic's product offerings but also positions the company as a leader in innovation within the bronchoscopy space.
 
The introduction of this system is likely to attract healthcare providers seeking cutting-edge solutions for respiratory diagnostics. In September 2025, Boston Scientific (US) entered into a partnership with a leading [telehealth](https://www.marketresearchfuture.com/reports/telehealth-market-900)provider to enhance remote monitoring capabilities for patients undergoing bronchoscopy procedures. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Boston Scientific is keen on integrating technology to improve patient outcomes and streamline workflows.
 
Such initiatives may enhance the company's competitive positioning in an increasingly digital healthcare landscape. In July 2025, Olympus Corporation (JP) expanded its manufacturing capabilities in Europe to better serve the growing demand for bronchoscopy products. This expansion reflects Olympus's commitment to regional growth and its strategy to optimize supply chain logistics. By increasing its production capacity, Olympus is likely to enhance its responsiveness to market needs, thereby strengthening its competitive stance.
 
As of October 2025, the Bronchoscopy Market is witnessing trends such as digitalization, sustainability, and the integration of [artificial intelligence](https://www.marketresearchfuture.com/reports/artificial-intelligence-market-1139). These trends are reshaping the competitive landscape, as companies increasingly focus on strategic alliances to enhance their technological capabilities. The shift from price-based competition to a focus on innovation and supply chain reliability is becoming evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, reliable, and sustainable solutions.

## Recent News & Developments

- **Q2 2024: Olympus launches EVIS X1, its most advanced endoscopy system, in the United States** Olympus announced the U.S. launch of its EVIS X1 endoscopy system, which includes advanced bronchoscopy capabilities designed to improve diagnostic and therapeutic procedures for respiratory diseases.
- **Q1 2024: Ambu receives FDA 510(k) clearance for Ambu® aScope™ 5 Broncho** Ambu announced it received FDA 510(k) clearance for its aScope 5 Broncho, a single-use bronchoscope designed for advanced bronchoscopy procedures in the U.S. market.
- **Q2 2024: Boston Scientific launches EXALT Model B single-use bronchoscope in Europe** Boston Scientific announced the commercial launch of its EXALT Model B single-use bronchoscope in select European markets, expanding its portfolio of disposable endoscopy solutions.
- **Q1 2024: Fujifilm launches new ELUXEO Ultra bronchoscopy system in Japan** Fujifilm introduced the ELUXEO Ultra bronchoscopy system in Japan, featuring enhanced imaging technology for improved detection and diagnosis of pulmonary diseases.
- **Q2 2024: Medtronic acquires privately held bronchoscopy device maker InterVapor for $350 million** Medtronic announced the acquisition of InterVapor, a company specializing in minimally invasive bronchoscopy devices for lung disease treatment, to strengthen its respiratory portfolio.
- **Q1 2024: Olympus and Veran Medical Technologies announce strategic partnership for advanced bronchoscopy navigation** Olympus and Veran Medical Technologies entered a partnership to integrate Veran’s navigation technology with Olympus’ bronchoscopy systems, aiming to improve accuracy in lung cancer diagnosis.
- **Q2 2024: Ambu opens new manufacturing facility for single-use endoscopes in Mexico** Ambu inaugurated a new manufacturing facility in Mexico to increase production capacity for its single-use bronchoscopes and meet growing global demand.
- **Q1 2024: Boston Scientific receives CE Mark for EXALT Model B single-use bronchoscope** Boston Scientific announced it received CE Mark approval for its EXALT Model B single-use bronchoscope, allowing commercialization in the European Union.
- **Q2 2024: Fujifilm opens new R&D center for endoscopy innovation in Germany** Fujifilm opened a new research and development center in Germany focused on advancing endoscopy and bronchoscopy technologies for the European market.
- **Q1 2024: Karl Storz appoints new CEO to drive digital transformation in endoscopy** Karl Storz announced the appointment of a new CEO, emphasizing a strategic focus on digital innovation and expansion in the bronchoscopy and endoscopy sectors.
- **Q2 2024: Olympus receives FDA clearance for BF-UC190F endobronchial ultrasound bronchoscope** Olympus announced it received FDA clearance for its BF-UC190F endobronchial ultrasound bronchoscope, expanding its portfolio of advanced diagnostic tools for lung cancer.
- **Q1 2024: Ambu secures contract to supply single-use bronchoscopes to major U.S. hospital network** Ambu announced it secured a multi-year contract to supply its single-use bronchoscopes to a leading U.S. hospital network, supporting infection control and procedural efficiency.

## Report Scope

| MARKET SIZE 2024 | 2.894(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 3.114(USD Billion) |
| MARKET SIZE 2035 | 6.479(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.6% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Boston Scientific (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP), Conmed Corporation (US), Hoya Corporation (JP), Ambu A/S (DK) |
| Segments Covered | Product, Usability, Application, End User, Region |
| Key Market Opportunities | Integration of advanced imaging technologies enhances diagnostic accuracy in the market. |
| Key Market Dynamics | Technological advancements in bronchoscopy are driving enhanced diagnostic capabilities and improving patient outcomes. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Bronchoscopy Market by 2035?**
A: The market is projected to reach a valuation of 6.479 USD Billion by 2035.

**Q: What was the market valuation of the market in 2024?**
A: In 2024, the market was valued at 2.894 USD Billion.

**Q: What is the expected CAGR for the Bronchoscopy Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period 2025 - 2035 is 7.6%.

**Q: Which companies are considered key players in the market?**
A: Key players in the market include Medtronic, Boston Scientific, Olympus Corporation, Karl Storz, Fujifilm Holdings Corporation, Conmed Corporation, Hoya Corporation, and Ambu A/S.

**Q: What are the main product segments in the Bronchoscopy Market?**
A: The main product segments in the market include Endoscopes, Visualization & Documentation Systems, Accessories, and Others.

**Q: How did the valuation of disposable equipment compare to reusable equipment in 2024?**
A: In 2024, the valuation for disposable equipment was 1.447 USD Billion, matching that of reusable equipment.

**Q: What is the projected valuation for bronchial diagnosis by 2035?**
A: The projected valuation for bronchial diagnosis is expected to reach 3.295 USD Billion by 2035.

**Q: What end-user segments are included in the Bronchoscopy Market?**
A: End-user segments in the market include Hospitals & Clinics, Ambulatory Surgery Centers, and Others.

**Q: What was the valuation of visualization and documentation systems in 2024?**
A: In 2024, the valuation of visualization and documentation systems was 0.8 USD Billion.

**Q: What is the expected growth trend for the Bronchoscopy Market in the coming years?**
A: The market is anticipated to experience robust growth, with a projected valuation increase to 6.479 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/bronchoscopy-market-11508*